Clinical Trials Logo

Clinical Trial Summary

An open, multicenter, randomised, parallel group pilot study to investigate two different polyclonal rabbit immunoglobulin preparations for safety and efficacy: A comparison of ATG-Fresenius S to Thymoglobulin in prophylaxis for immunological high risk patients following renal transplantation. This non-inferiority trial shall demonstrate that ATG-Fresenius S is as efficacious as Thymoglobulin but has a better tolerance and fewer side effects.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00861536
Study type Interventional
Source University Hospital, Basel, Switzerland
Contact
Status Completed
Phase Phase 4
Start date January 2009
Completion date February 2015

See also
  Status Clinical Trial Phase
Completed NCT00189735 - A Study to Evaluate FK778 in Kidney Transplant Patients Phase 2
Recruiting NCT01150487 - Paired Marrow Aspirations to Assess Assays in Sensitized Renal Allograft Recipients N/A
Completed NCT01656343 - Belatacept and Risk of Post-transplant Lymphoproliferative Disorder in US Renal Transplant Recipients
Completed NCT02625428 - IRB 14-009240, Does CEUS Positively Influence Selection of Biopsy Sites When Evaluating Transplant Kidneys? Phase 4
Not yet recruiting NCT00617474 - The Effect of Erythropoietin Usage in Renal Function After Kidney Transplantation, in Early Phase, in Contrast to Placebo Group Phase 1
Terminated NCT00365833 - CEC/EPC and Cardiovascular Risk in Renal Transplant Recipients N/A
Withdrawn NCT01496729 - Transversus Abdominis Plane (TAP) Block After Kidney Transplantation N/A
Completed NCT00614081 - GFR Measurement With Contrast-enhanced Dynamic MRI N/A
Completed NCT03977051 - Exploring Immunosuppressant Medication Adherence in Kidney Transplant Patients
Terminated NCT00568477 - Value of Rituximab in Humoral Chronic Rejection After Renal Transplantation Phase 2
Completed NCT04874740 - Seroprevalence of the Anti-SARS-CoV-2 Antibodies (Causing COVID-19) in Kidney Transplant Recipients in Severely Affected Region
Available NCT01236287 - Special Access for the Use of Voclosporin for Kidney Transplantation